SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
绿小豆
Lv5
930 积分
2024-03-09 加入
最近求助
最近应助
互助留言
Network meta-analysis: efficacy and safety of treatments for fistulising Crohn’s disease
12天前
已完结
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
1个月前
已完结
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study
1个月前
已完结
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long‐term extension period of STARDUST
1个月前
已完结
Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naïve Crohn’s Disease
1个月前
已关闭
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn’s Disease
1个月前
已完结
Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study
1个月前
已完结
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn’s Disease (Versus-CD): Data from the ENEIDA Registry
1个月前
已完结
Predictors and Outcomes of Ustekinumab Dose Intensification in Ulcerative Colitis: A Multicenter Cohort Study
1个月前
已完结
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium
1个月前
已完结
没有进行任何应助
感谢
12天前
已找到【积分已退回】
1个月前
感谢
1个月前
感谢
1个月前
感谢
1个月前
感谢
1个月前
感谢
1个月前
感谢
1个月前
感谢
1个月前
感谢,点赞
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论